Will The $3bn Stimulus Amid COVID-19 Place Indian Cos Among Goliaths?
INR 51bn Investments Committed Under First PLI Scheme
Following an INR69bn incentive scheme for APIs, the Indian government has come up with an INR150bn scheme for formulations and more. Will this $3bn push prove to be the one that companies like Sun Pharma and Aurobindo, currently at 36 and 48 respectively in Scrip 100 rankings, need to break into the top league?
